Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 14, 2022
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
Justin Bowers Initiated (TXG) at Strong Buy and Held Target at $50 on, Dec 14th, 2022
Justin Bowers of Deutsche Bank, Initiated "10x Genomics, Inc." (TXG) at Strong Buy and Held Target at $50 on, Dec 14th, 2022.
Justin has made no other calls on TXG in the last 4 months.
There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 0 agree with Justin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Justin
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $64 on, Friday, November 4th, 2022
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $25 on, Thursday, October 13th, 2022
